Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice.
Glucagon-like peptide-1 (GLP-1) receptor agonists potentiate glucose-induced insulin secretion. In addition, they have been reported to increase pancreatic beta cell mass in diabetic rodents. However, the precise mode of action of GLP-1 receptor agonists still needs to be elucidated. Here we clarify...
Main Authors: | Kanako Tamura, Kohtaro Minami, Maya Kudo, Keisuke Iemoto, Harumi Takahashi, Susumu Seino |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4418765?pdf=render |
Similar Items
-
Beta Cell Mass Restoration in Alloxan-Diabetic Mice Treated with EGF and Gastrin.
by: Imane Song, et al.
Published: (2015-01-01) -
Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia.
by: Angeles Mondragon, et al.
Published: (2014-01-01) -
Cholesterol gallstones in alloxan-diabetic mice.
by: T Akiyoshi, et al.
Published: (1990-04-01) -
Profile of blood glucose and ultrastucture of beta cells pancreatic islet in alloxan compound induced rats
by: I Nyoman Suarsana, et al.
Published: (2010-06-01) -
Liraglutide in Adults with Type 2 Diabetes: Global Perspective on Safety, Efficacy and Patient Preference
by: Daisuke Yabe, et al.
Published: (2011-01-01)